Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ. Baumgart DC, et al. Inflamm Bowel Dis. 2010 Apr;16(4):620-9. doi: 10.1002/ibd.21084. Inflamm Bowel Dis. 2010. PMID: 19714757 Clinical Trial.
Intestinal barrier function.
Baumgart DC, Dignass AU. Baumgart DC, et al. Curr Opin Clin Nutr Metab Care. 2002 Nov;5(6):685-94. doi: 10.1097/00075197-200211000-00012. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12394645 Review.
Lipoxins and resolvins in inflammatory bowel disease.
Weylandt KH, Kang JX, Wiedenmann B, Baumgart DC. Weylandt KH, et al. Among authors: baumgart dc. Inflamm Bowel Dis. 2007 Jun;13(6):797-9. doi: 10.1002/ibd.20109. Inflamm Bowel Dis. 2007. PMID: 17262807 Review.
166 results